LUXIN OPTICAL
✅ Low Risk
FEI: 3012716071 • Shanghai, Shanghai • CHINA
FEI Number
3012716071
Location
Shanghai, Shanghai
Country
CHINAAddress
Unit 1001, No 1118 Pu Dong South Rd, Shanghai, Shanghai, China
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/31/2017 | 86HQZFRAME, SPECTACLE | 341REGISTERED | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is LUXIN OPTICAL's FDA import refusal history?
LUXIN OPTICAL (FEI: 3012716071) has 1 FDA import refusal record(s) in our database, spanning from 10/31/2017 to 10/31/2017.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. LUXIN OPTICAL's FEI number is 3012716071.
What types of violations has LUXIN OPTICAL received?
LUXIN OPTICAL has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about LUXIN OPTICAL come from?
All FDA import refusal data for LUXIN OPTICAL is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.